Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1761]

FDA approves lirafugratinib for previously treated, unresectable, locally advanced or metastatic cholangiocarcinoma

FDA approves lirafugratinib for previously treated, unresectable, locally advanced or metastatic cholangiocarcinoma

Loss of Y chromosome in men could be early warning sign of cancer

Loss of Y chromosome in men could be early warning sign of cancer

The dawn of RAS-targeted therapy: a landmark breakthrough of daraxonrasib in pancreatic cancer

The dawn of RAS-targeted therapy: a landmark breakthrough of daraxonrasib in pancreatic cancer

Faecal microbial signatures show promise for colorectal and pancreatic cancer assessment

Faecal microbial signatures show promise for colorectal and pancreatic cancer assessment

New study: Blood test shows promise for detecting pancreatic cancer at its earliest stages

New study: Blood test shows promise for detecting pancreatic cancer at its earliest stages

Blood test shows promise for detecting pancreatic cancer at its earliest stages

Blood test shows promise for detecting pancreatic cancer at its earliest stages

Faecal microbiota transplantation may improve immunotherapy-related colitis

Faecal microbiota transplantation may improve immunotherapy-related colitis

First-in-human study attacks pancreatic cancer with laser light

First-in-human study attacks pancreatic cancer with laser light

Tiny tumour-triggered patches turn immune cells into cancer fighters

Tiny tumour-triggered patches turn immune cells into cancer fighters

Mini-tumours reveal new drug combinations for liver cancer

Mini-tumours reveal new drug combinations for liver cancer

More from ecancer